Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. (2016)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/tpj.2016.41
PubMed Identifier: 27272045
Publication URI: http://europepmc.org/abstract/MED/27272045
Type: Journal Article/Review
Volume: 16
Parent Publication: The pharmacogenomics journal
Issue: 5
ISSN: 1470-269X